Telehealth treatment for opioid addiction is working. Pandemic flexibilities helped Americans access life-saving medications like buprenorphine without increasing misuse. So why are we going backward? The DEA’s newly proposed “guardrails” are more aptly “roadblocks” for addiction patients and providers alike.

The DEA announced a proposal for new rules for prescribing controlled substances - including buprenorphine - that could impact telehealth patients and add a single in-person requirement. Boulder is prepared to help patients navigate this change and fight back to make treatment easy and accessible.

When the stigma of abortion is added to other forms of stigma, dangerous forces multiply. From her work delivering both reproductive and SUD care to patients in need, Dr. Amy Potter shares her firsthand perspective about the impact of the SCOTUS ruling.

Dave Lerman, Boulder's CTO, details how a personal experience helped him see a need for more support and funding for studies into the potential of psychedelics.

Boulder Care’s Medical Director, Alyson Smith, and Community Justice expert, Jeremy Hubbard, explain why incarceration creates such dangerous situations for SUD patients -- and what can be done about it.

Ben MacLean, Boulder's General Counsel, explains how laws and regulations can fight against patients with SUDs and stand in the way of better treatment options.

Boulder's in-house writer, Michael, who also works in TV and film, explains how Hollywood's obsession with sad stories has created a distorted view of patients with substance use disorder.

Jeremy Hubbard discusses what he learned in his 16 year career as a parole officer about what the criminal justice system gets wrong around substance use disorder, treatment, and helping inmates with addictions.